Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Yogen Saunthararajah, MD
Researcher Professor of Medicine
Cleveland Clinic Main Campus
9500 Euclid Avenue
Cleveland, Ohio, United States
Yogen Saunthararajah, MD, is a staff in the department of Hematologic Oncology and Blood Disorders at Cleveland Clinic, a professor of medicine, and co-leader of the developmental therapeutics program of the Case Comprehensive Cancer Center.
His clinical and research interests include acute myeloid leukemia, myelodysplastic syndrome, sickle cell disease/anemia, thalassemia, leukemia, benign hematology, myelodysplasia, cancer, leukopenia, aplastic anemia.
Dr. Yogen developed an Epigenetic Platform that has the potential to identify and eliminate the “road blocks” that prevent cancer cells from becoming specialized, non-dividing cells. According to him, the methodology can be applied to some of the most common and most debilitating genetic disorders in the world, including sickle cell disease and beta thalassemia.
+myBinderRelated Content
-
Teens with Sickle Cell Disease Moving from Pediatric Care to Adult CareMoving from pediatric (children’s) car...
-
Hannah S. Lichtsinn, MDHannah S. Lichtsinn is MD in internal me...
-
Impact of emergency department care on outcomes of acute pain events in children with sickle cell diseaseThe impact of emergency department (ED) ...
-
2019 Chicago Sickle Cell SummitThe Chicago Sickle Cell Summit convenes ...
-
Sickle cell patients in UK survey, especially those 16 to 20, voice problems with care and pain relief givenIn a survey, patients across the...
-
Minority Health Counts: Building a More Equitable Community SummitBy Supporters of Families with Sickle Ce...
-
Shelley Crary, MD, MSDr. Shelley Crary received her undergrad...
